查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1595316

藥用明膠市場：按來源、類型、特徵和應用分類 - 2025-2030 年全球預測

Pharmaceutical Gelatin Market by Source (Bovine Bone, Bovine Skin, Marine), Type (Type A, Type B), Function, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年藥用明膠市場價值為12億美元，預計2024年將達12.8億美元，複合年成長率為6.44%，預計2030年將達到18.6億美元。

藥用明膠是一種重要的賦形劑，主要用於膠囊殼和錠劑配方以及作為各種藥品的穩定劑。其需求是由於其生物相容性和快速溶解能力，使其成為向人體輸送藥物的理想選擇。明膠最常見的用途是軟膠囊、硬膠囊和血漿替代。最終用途部門主要是生產口服、眼科和局部給藥系統的製藥公司。

主要市場統計
基準年[2023] 12億美元
預測年份 [2024] 12.8億美元
預測年份 [2030] 18.6億美元
複合年成長率（%） 6.44%

由於膠囊易於攝取且生物利用度提高，藥用明膠市場受到膠囊需求不斷成長的顯著影響。除了非傳染性疾病的快速增加之外，老年人口的增加也推動了對明膠的需求。監管機構對改善給藥系統的關注進一步推動了該領域的創新。特別是，隨著素食趨勢的成長和消費者對動物福利意識的提高，市場面臨著開發替代植物來源明膠的機會。公司可以透過投資新型永續明膠配方的研發來利用這一點。從地理位置來看，亞太地區的新興市場，特別是中國和印度，由於醫療基礎設施的擴大和消費者在藥品上的支出增加，潛力巨大。

然而，市場面臨限制，包括嚴格的監管標準、原料價格波動以及牛和豬的採購，特別是由於牛腦病變（BSE）等疾病的爆發。挑戰在於平衡成本、品質和遵守良好生產規範 (GMP) 等國際標準。

創新領域包括生物工程明膠以增強機械性能和穩定性的分子控制，以及明膠在定製藥物傳輸系統中的使用。此外，製藥公司和研究機構之間的合作研究舉措可以帶來創新的產品應用和配方。市場需要敏捷性，企業必須跟上技術進步和不斷變化的消費者偏好，以保持競爭力。

市場動態：揭示快速發展的藥用明膠市場的關鍵市場洞察

供需的動態交互作用正在改變藥用明膠市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 藥用明膠的大規模使用
    • 慢性病及感染疾病流行
    • 臨床試驗和藥物前期研究增加
  • 市場限制因素
    • 與藥用明膠相關的高成本
  • 市場機會
    • 明膠奈米粒子在疫苗和藥物傳輸的最新進展
    • 改善供應鏈和分銷網路
  • 市場挑戰
    • 對藥用明膠安全和品質的擔憂

波特五力：駕馭藥用明膠市場的策略工具

波特的五力框架是了解藥用明膠市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對藥用明膠市場的影響

外部宏觀環境因素在塑造藥用明膠市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解藥用明膠市場的競爭狀況

對藥用明膠市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣藥用明膠市場供應商績效評估

FPNV 定位矩陣是評估藥用明膠市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，描繪藥用明膠市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，藥用明膠市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 明膠在藥物劑量中的大規模使用
      • 慢性病和感染疾病的盛行率
      • 臨床試驗和初步藥物研究的增加
    • 抑制因素
      • 與藥用明膠相關的高成本
    • 機會
      • 明膠奈米粒子在疫苗和藥物傳輸的最新進展
      • 改善供應鏈和分銷網路
    • 任務
      • 對藥用明膠安全和品質的擔憂
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章藥用明膠市場：依來源分類

  • 牛
  • 牛皮
  • 海洋
  • 豬肉
  • 家禽

第7章藥用明膠市場：依類型

  • A型
  • B型

第8章藥用明膠市場：依功能分類

  • 膠凝劑
  • 穩定劑
  • 增稠劑

第9章藥用明膠市場：依應用分類

  • 可吸收止血材料
  • 硬膠囊
  • 軟膠囊
  • 藥片

第10章美洲藥用明膠市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太藥用明膠市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲藥用明膠市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Gelco International
  • Gelita AG
  • Gelnex
  • Geltec Private Limited
  • Geltech Co. Ltd.
  • Henan Boom Gelatin Co. Ltd.
  • India Gelatine & Chemicals Ltd.
  • Italgel Srl
  • Junca Gelatines SL
  • Kenney & Ross Limited
  • Lapi Gelatine SpA
  • SAS Gelatines Weishardt
  • Tessenderlo Group NV
  • Toudongbao Biotechnology Co., Ltd.
  • Xiamen Gelken Gelatin Co., Ltd.
Product Code: MRR-4F4C36263656

The Pharmaceutical Gelatin Market was valued at USD 1.20 billion in 2023, expected to reach USD 1.28 billion in 2024, and is projected to grow at a CAGR of 6.44%, to USD 1.86 billion by 2030.

Pharmaceutical gelatin is a critical excipient used primarily in the formulation of capsule shells, tablets, and as a stabilizer in various medicinal products. Its necessity stems from its biocompatibility and ability to dissolve rapidly, making it ideal for drug delivery in the human body. Gelatin's most common applications are in soft gel capsules, hard capsules, and blood plasma substitutes. End-use sectors primarily include pharmaceutical companies manufacturing oral, ophthalmic, and topical delivery systems.

KEY MARKET STATISTICS
Base Year [2023] USD 1.20 billion
Estimated Year [2024] USD 1.28 billion
Forecast Year [2030] USD 1.86 billion
CAGR (%) 6.44%

The market for pharmaceutical gelatin is significantly influenced by the rising demand for capsules due to their ease of consumption and improved bioavailability. An increasing geriatric population, alongside the surging occurrence of non-communicable diseases, boosts gelatin demand. Regulatory bodies' emphasis on improving drug delivery systems further fuels innovation in this sector. Notably, the market faces opportunities in developing plant-based gelatin alternatives, driven by a growing veganism trend and rising consumer awareness regarding animal welfare. Companies can capitalize on this by investing in R&D toward novel, sustainable gelatin formulations. Geographically, emerging markets in Asia-Pacific, particularly China and India, offer vast potential due to expanding healthcare infrastructure and rising consumer spending on pharmaceuticals.

However, the market confronts limitations, including stringent regulatory norms and volatility in raw material prices, especially concerning bovine and porcine sourcing due to disease outbreaks like Bovine Spongiform Encephalopathy (BSE). The challenge lies in balancing cost, quality, and compliance with international standards such as Good Manufacturing Practices (GMP).

Innovative areas include bio-engineered gelatin, which enhances molecular control over mechanical properties and stability, and gelatin's utilization in customized drug delivery systems. Moreover, collaborative research initiatives between pharmaceutical companies and research institutions may yield innovative product applications and formulations. The market demands agility, requiring firms to synchronize with technological advancements and evolving consumer preferences to maintain a competitive edge.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmaceutical Gelatin Market

The Pharmaceutical Gelatin Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Large scale use of gelatin in pharma drug dosage
    • Prevalence of chronic and infectious disorders
    • Increasing clinical trials and preliminary drug studies
  • Market Restraints
    • High cost associated with Pharmaceutical Gelatin
  • Market Opportunities
    • Recent advancements in gelatin nanoparticle in vaccine and drug delivery
    • Improvements in supply chain and distribution network
  • Market Challenges
    • Safety and quality concerns with pharmaceutical gelatin

Porter's Five Forces: A Strategic Tool for Navigating the Pharmaceutical Gelatin Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmaceutical Gelatin Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmaceutical Gelatin Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmaceutical Gelatin Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmaceutical Gelatin Market

A detailed market share analysis in the Pharmaceutical Gelatin Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmaceutical Gelatin Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmaceutical Gelatin Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmaceutical Gelatin Market

A strategic analysis of the Pharmaceutical Gelatin Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Gelatin Market, highlighting leading vendors and their innovative profiles. These include Gelco International, Gelita AG, Gelnex, Geltec Private Limited, Geltech Co. Ltd., Henan Boom Gelatin Co. Ltd., India Gelatine & Chemicals Ltd., Italgel S.r.l., Junca Gelatines SL, Kenney & Ross Limited, Lapi Gelatine S.p.A, SAS Gelatines Weishardt, Tessenderlo Group NV, Toudongbao Biotechnology Co., Ltd., and Xiamen Gelken Gelatin Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Gelatin Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Source, market is studied across Bovine Bone, Bovine Skin, Marine, Porcine, and Poultry.
  • Based on Type, market is studied across Type A and Type B.
  • Based on Function, market is studied across Gelling Agents, Stabilizing Agents, and Thickening Agents.
  • Based on Application, market is studied across Absorbable Hemostats, Hard Capsules, Soft Capsules, and Tablets.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Large scale use of gelatin in pharma drug dosage
      • 5.1.1.2. Prevalence of chronic and infectious disorders
      • 5.1.1.3. Increasing clinical trials and preliminary drug studies
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with Pharmaceutical Gelatin
    • 5.1.3. Opportunities
      • 5.1.3.1. Recent advancements in gelatin nanoparticle in vaccine and drug delivery
      • 5.1.3.2. Improvements in supply chain and distribution network
    • 5.1.4. Challenges
      • 5.1.4.1. Safety and quality concerns with pharmaceutical gelatin
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pharmaceutical Gelatin Market, by Source

  • 6.1. Introduction
  • 6.2. Bovine Bone
  • 6.3. Bovine Skin
  • 6.4. Marine
  • 6.5. Porcine
  • 6.6. Poultry

7. Pharmaceutical Gelatin Market, by Type

  • 7.1. Introduction
  • 7.2. Type A
  • 7.3. Type B

8. Pharmaceutical Gelatin Market, by Function

  • 8.1. Introduction
  • 8.2. Gelling Agents
  • 8.3. Stabilizing Agents
  • 8.4. Thickening Agents

9. Pharmaceutical Gelatin Market, by Application

  • 9.1. Introduction
  • 9.2. Absorbable Hemostats
  • 9.3. Hard Capsules
  • 9.4. Soft Capsules
  • 9.5. Tablets

10. Americas Pharmaceutical Gelatin Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Pharmaceutical Gelatin Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Pharmaceutical Gelatin Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Gelco International
  • 2. Gelita AG
  • 3. Gelnex
  • 4. Geltec Private Limited
  • 5. Geltech Co. Ltd.
  • 6. Henan Boom Gelatin Co. Ltd.
  • 7. India Gelatine & Chemicals Ltd.
  • 8. Italgel S.r.l.
  • 9. Junca Gelatines SL
  • 10. Kenney & Ross Limited
  • 11. Lapi Gelatine S.p.A
  • 12. SAS Gelatines Weishardt
  • 13. Tessenderlo Group NV
  • 14. Toudongbao Biotechnology Co., Ltd.
  • 15. Xiamen Gelken Gelatin Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. PHARMACEUTICAL GELATIN MARKET RESEARCH PROCESS
  • FIGURE 2. PHARMACEUTICAL GELATIN MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. PHARMACEUTICAL GELATIN MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. PHARMACEUTICAL GELATIN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL GELATIN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PHARMACEUTICAL GELATIN MARKET DYNAMICS
  • TABLE 7. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY BOVINE BONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY BOVINE SKIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY MARINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY PORCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE A, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE B, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY GELLING AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY STABILIZING AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY THICKENING AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY ABSORBABLE HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY HARD CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOFT CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. PHARMACEUTICAL GELATIN MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 194. PHARMACEUTICAL GELATIN MARKET, FPNV POSITIONING MATRIX, 2023